US Stock MarketDetailed Quotes
CELG.RT BRISTOL-MYERS SQUIBB CO CELGENE CONTINGENT VAL RIGHTS 12/31/2030
- 0.0501
- -0.0029-5.47%
Close May 7 16:00 ET
- 0.0501
- 0.00000.00%
Post 16:00 ET
0Market Cap0.00P/E (TTM)
0.0515High0.0501Low1.27KVolume0.0515Open0.0530Pre Close65.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.084352wk High0.00P/B0Float Cap0.011652wk Low--Dividend TTM0Shs Float0.1066Historical High--Div YieldTTM2.64%Amplitude0.0116Historical Low0.0510Avg Price1Lot Size
BRISTOL-MYERS SQUIBB CO CELGENE CONTINGENT VAL RIGHTS 12/31/2030 News
BRISTOL-MYERS SQUIBB CO CELGENE CONTINGENT VAL RIGHTS 12/31/2030 To Go Ex-Dividend On March 7th, 2024 With 0.0199 USD Dividend Per Share
February 24th - $BRISTOL-MYERS SQUIBB CO CELGENE CONTINGENT VAL RIGHTS 12/31/2030(CELG.RT.US)$ is trading ex-dividend on March 7th, 2024. Shareholders of record on March 9th, 2024 will receive 0.0
Regenerative Medicine Market Size to Worth USD 95 Billion by 2032
The regenerative medicine market size surpassed 16.55 billion in 2023 and is growing at a healthy CAGR of 21.4% between 2023 and 2032, as a result of the rising demand for cell and gene therapies.
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg